Royce Global Value Trust, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Christopher Dewitt Clark
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 745 Fifth Avenue New York City NY United States of America 10151
- IPO Date
- Oct 9, 2013
- CIK
- 0001514490
- Website
- royceinvest.com
- Similar Companies
- Business
- Royce Global Trust Royce Global Trust, Inc. (RGT) operates as a diversified closed-end investment company focused on long-term capital growth through a disciplined value investing approach in global small-cap and mid-cap equities; it allocates at least 80% of net assets to equity securities such as common and preferred stocks, with at least 65% in companies located in at least three countries outside the United States, spanning sectors including consumer discretionary, technology, healthcare, and industrials. The fund, managed by Royce & Associates, LP (formerly Royce Investment Partners), targets value-oriented stocks of small- and micro-cap companies across U.S. and non-U.S. markets, providing investors broad geographic exposure to regions such as the UK, Europe, Asia, and emerging markets while benchmarking performance against the Russell Global Small Cap Index. Founded in 1986 and headquartered at One Madison Avenue in New York, New York, the fund serves institutional and retail investors seeking diversified international small-cap value strategies. In a key recent development effective May 1, 2024, Royce Global Trust simplified its name from Royce Global Value Trust, Inc. to Royce Global Trust, Inc., with no alterations to its investment objective or policies, reflecting a strategic rebranding to emphasize its global focus. The fund maintains regular distributions, including income, long-term capital gains, short-term gains, and return of capital, with recent payouts supporting a trailing dividend yield of approximately 3.71% as of late 2025; its average weekly trading volume stands at around 65,000 shares. Portfolio managers, including Steven G. McBoyle, oversee a broadly diversified holdings list with over 50 years of small- and micro-cap expertise from the adviser, amid ongoing market volatility in global equities.
Royce Global Trust, Inc. (NYSE-RGT) declares Year-end Common Stock Distribution of $0.19 Per Share
Royce Global Trust (NYSE: RGT) as of Oct 31, 2025
Royce Global Trust (NYSE: RGT) as of Sep 30, 2025
Royce Global Trust (NYSE: RGT) as of Aug 31, 2025
Royce Global Trust (NYSE: RGT) as of Jul 31, 2025
Royce Global Trust (NYSE: RGT) as of Jun 30, 2025
RGT: Deep Discount On Global Small-Caps But Unappealing Distribution Policy
Royce Global Trust (NYSE: RGT) as of Mar 31, 2025
Argent BioPharma Enters Germany - Europe's Largest Market
Royce Global Trust (NYSE: RGT) as of Feb 28, 2025
Argent BioPharma Expands Pipeline with Promising Drug CimetrA®
Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management
Royce Global Trust (NYSE: RGT) as of Dec 31, 2024
Argent BioPharma Ltd. Raised US$4,500,000
Argent BioPharma Ltd. Placing to Raise US$4,500,000
Royce Global Trust, Inc. (NYSE-RGT) declares Year-end Common Stock Distribution of $0.47 Per Share
Royce Global Trust (NYSE: RGT) as of Oct 31, 2024
Royce Global Trust (NYSE: RGT) as of Sep 30, 2024
Royce Global Trust (NYSE: RGT) as of Jul 31, 2024
Royce Global Trust (NYSE: RGT) as of Apr 30, 2024